Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:705  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1New parasite inhibitors encompassing novel conformationally-locked 5'-acyl sulfamoyl adenosines
Shailesh S. Dixit,Ram Shankar Upadhayaya,Jyoti Chattopadhyaya
Organic & Biomolecular Chemistry.2012;10(30)6121
[DOI]
2Overview of treatment options for invasive fungal infections
Melanie W. Pound,Mary L. Townsend,Vincent Dimondi,Dustin Wilson,Richard H. Drew
Medical Mycology.2011;10(30)1
[DOI]
3Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs
Vadiraj S. Gopinath,Mukkavilli Rao,Rahul Shivahare,Preeti Vishwakarma,Sweta Ghose,Ashok Pradhan,Ramamohan Hindupur,Koushik Das Sarma,Suman Gupta,Sunil K. Puri,Delphine Launay,Denis Martin
Bioorganic & Medicinal Chemistry Letters.2014;24(9)2046
[DOI]
4Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus
Sukhbir Kaur,Kalpana Chauhan,Heena Sachdeva
Journal of Medical Microbiology.2014;63(10)1328
[DOI]
5Nutrition, malnutrition, and leishmaniasis
Justus Amuche Nweze,Emeka Innocent Nweze,Uwakwe Simon Onoja
Nutrition.2020;73(10)110712
[DOI]
6Molecular factors governing inhibition of arylimidamides against Leishmania: Conservative computational modeling to improve chemotherapies
Catharine J. Collar,Xiaohua Zhu,Karl Werbovetz,David W. Boykin,W. David Wilson
Bioorganic & Medicinal Chemistry.2011;19(15)4552
[DOI]
7Molecular factors governing inhibition of arylimidamides against Leishmania: Conservative computational modeling to improve chemotherapies
M. Freissmuth
Bioorganic & Medicinal Chemistry.2012;19(15)710
[DOI]
8Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
REBECCA L. CHARLTON,BARTIRA ROSSI-BERGMANN,PAUL W. DENNY,PATRICK G. STEEL
Parasitology.2018;145(2)219
[DOI]
9Marine Algae as Source of Novel Antileishmanial Drugs: A Review
Lauve Tchokouaha Yamthe,Regina Appiah-Opong,Patrick Tsouh Fokou,Nole Tsabang,Fabrice Fekam Boyom,Alexander Nyarko,Michael Wilson
Marine Drugs.2017;15(11)323
[DOI]
10Unveiling the Targets Involved in the Quest of Antileishmanial Leads Using In silico Methods
Pone K. Boniface,Cinthya M. Sano,Ferreira I. Elizabeth
Current Drug Targets.2020;21(7)681
[DOI]
11Identification of Novel Inhibitors of Leishmania donovani ?-Glutamylcysteine Synthetase Using Structure-Based Virtual Screening, Docking, Molecular Dynamics Simulation, and in Vitro Studies
Pragati Agnihotri,Arjun K. Mishra,Shikha Mishra,Vijay Kumar Sirohi,Amogh A. Sahasrabuddhe,J. Venkatesh Pratap
Journal of Chemical Information and Modeling.2017;57(4)815
[DOI]
12Potential Antileishmanial Activity of a Triazole-Based Hybrid Peptide against Leishmania major
Krishnendu Maji,Mazharul Abbasi,Debasish Podder,Rupak Datta,Debasish Haldar
ChemistrySelect.2018;3(36)10220
[DOI]
13Potential Antileishmanial Activity of a Triazole-Based Hybrid Peptide against Leishmania major
Kavya Desai,Campbell Stewart
ChemistrySelect.2020;3(36)167
[DOI]
14Potential Antileishmanial Activity of a Triazole-Based Hybrid Peptide against Leishmania major
Ganesh Yadagiri,Prati Pal Singh
ChemistrySelect.2018;3(36)63
[DOI]
15Chemotherapy of leishmaniasis part X: Synthesis and bioevaluation of novel terpenyl heterocycles
Avinash Tiwari,Santosh Kumar,S.N. Suryawanshi,Monika Mittal,Preeti Vishwakarma,Suman Gupta
Bioorganic & Medicinal Chemistry Letters.2013;23(1)248
[DOI]
16Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue
Pone Kamdem Boniface,Elizabeth Igne Ferreira
Phytotherapy Research.2019;33(10)2473
[DOI]
17Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases
Beatriz Costa-Carvalho,Maria González-Serrano,Sara Espinosa-Padilla,Gesmar Segundo
Expert Review of Clinical Immunology.2017;13(5)483
[DOI]
18In VitroActivities of New 2-Substituted Quinolines againstLeishmania donovani
Philippe M. Loiseau,Suman Gupta,Aditya Verma,Saumya Srivastava,S. K. Puri,Faten Sliman,Marie Normand-Bayle,Didier Desmaele
Antimicrobial Agents and Chemotherapy.2011;55(4)1777
[DOI]
19In vitro Effects of Ketotifen and Cromolyn Sodium on Promastigote and Amastigotes of Leishmania major
Lima Asgharpour Sarouey,Khadijeh Khanaliha,Parvaneh Rahimi-Moghaddam,Samaneh Khorrami,Mohammad Saaid Dayer,Fatemeh Tabatabaie
Jundishapur Journal of Microbiology.2018;In Press(In Press)1777
[DOI]
20Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment
Isabela Viol Valle,Monique Etnea Machado,Cristina da Costa Bernardes Araújo,Edézio Ferreira da Cunha-Junior,Juliana da Silva Pacheco,Eduardo Caio Torres-Santos,Luiz Cláudio Rodrigues Pereira da Silva,Lucio Mendes Cabral,Flávia Almada do Carmo,Plínio Cunha Sathler
Nanotechnology.2019;30(45)455102
[DOI]
21A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies
Muzamil Yaqub Want,Mohammad Islamuddin,Garima Chouhan,Anjan Kumar Dasgupta,Asoke Prasun Chattopadhyay,Farhat Afrin
Journal of Colloid and Interface Science.2014;432(45)258
[DOI]
22A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies
Neeraj Tiwari,Arun Kumar,Ashish K. Singh,Surabhi Bajpai,Anand K. Agrahari,Dhiraj Kishore,Vinod K. Tiwari,Rakesh K. Singh
Journal of Colloid and Interface Science.2019;432(45)293
[DOI]
23Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis
Rishikesh Kumar,Krishna Pandey,Ganesh C Sahoo,Susmita Das,VNR Das,RK Topno,Pradeep Das
Materials Science and Engineering: C.2017;75(45)1465
[DOI]
24Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening
Lorenzo Turcano,Esther Torrente,Antonino Missineo,Matteo Andreini,Marina Gramiccia,Trentina Di Muccio,Ilaria Genovese,Annarita Fiorillo,Steven Harper,Alberto Bresciani,Gianni Colotti,Andrea Ilari,Sandhya Kortagere
PLOS Neglected Tropical Diseases.2018;12(11)e0006969
[DOI]
25Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium
Igor Grekov,Milena Svobodová,Eva Nohýnková,Marie Lipoldová
Journal of Microbiological Methods.2011;87(3)273
[DOI]
26Antileishmanial Activity of Warifteine: A Bisbenzylisoquinoline Alkaloid Isolated fromCissampelos sympodialisEichl. (Menispermaceae)
Eliete Cavalcanti da Silva,Cynthia Dias Rayol,Paloma Lys Medeiros,Regina Célia Bressan Queiroz Figueiredo,Márcia Regina Piuvezan,José Maria Brabosa-Filho,Alexsandro Fernandes Marinho,Teresinha Gonçalves Silva,Gardenia Carmen Gadelha Militão,Ana Paula Pimentel Cassilhas,Paulo Paes de Andrade
The Scientific World Journal.2012;2012(3)1
[DOI]
27A New Approach To The Treatment of Leishmaniasis: Quercetin-Loaded Polycaprolactone Nanoparticles
Emrah Sefik Abamor
Journal of the Turkish Chemical Society, Section A: Chemistry.2018;2012(3)1071
[DOI]
28Kala Azar – letaler Verlauf einer viszeralen Leishmaniose
C. Posch,J. Walochnik,A. Gschnait,H. Feichtinger,K. Rappersberger
Der Hautarzt.2012;63(12)947
[DOI]
29Leishmaniasis
Elinor M Moore,Diana N Lockwood
Clinical Medicine.2011;11(5)492
[DOI]
30Leishmaniasis
Rose Hayeshi,Boitumelo Semete,Lonji Kalombo,Yolandy Lemmer,Lebogang Katata,Hulda Swai
Clinical Medicine.2013;11(5)491
[DOI]
31Leishmania infantum mimotopes and a phage–ELISA assay as tools for a sensitive and specific serodiagnosis of human visceral leishmaniasis
Beatriz C.S. Salles,Lourena E. Costa,Patrícia T. Alves,Ana C.S. Dias,Emília R. Vaz,Daniel Menezes-Souza,Fernanda F. Ramos,Mariana C. Duarte,Bruno M. Roatt,Miguel A. Chávez-Fumagalli,Carlos A.P. Tavares,Denise U. Gonçalves,Regina L. Rocha,Luiz R. Goulart,Eduardo A.F. Coelho
Diagnostic Microbiology and Infectious Disease.2017;87(3)219
[DOI]
32Chemotherapy of leishmaniasis. Part XI: Synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives
S.N. Suryawanshi,Avinash Tiwari,Naveen Chandra,Naveen Ramesh,Suman Gupta
Bioorganic & Medicinal Chemistry Letters.2012;22(21)6559
[DOI]
33Chemotherapy of leishmaniasis. Part XI: Synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives
Michael Freissmuth
Bioorganic & Medicinal Chemistry Letters.2020;22(21)821
[DOI]
34Increased Glycolytic ATP Synthesis Is Associated with Tafenoquine Resistance inLeishmania major
José Ignacio Manzano,Luis Carvalho,José M. Pérez-Victoria,Santiago Castanys,Francisco Gamarro
Antimicrobial Agents and Chemotherapy.2011;55(3)1045
[DOI]
35Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis
Michael D. Lewis,Andrea Paun,Audrey Romano,Harry Langston,Charlotte A. Langner,Ian N. Moore,Kevin W. Bock,Amanda Fortes Francisco,Jason M. Brenchley,David L. Sacks,Edward Mitre
PLOS Pathogens.2020;16(4)e1008456
[DOI]
36Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads
Timothy J. Hubin,Ashlie N. Walker,Dustin J. Davilla,TaRynn N. Carder Freeman,Brittany M. Epley,Travis R. Hasley,Prince N.A. Amoyaw,Surendra Jain,Stephen J. Archibald,Timothy J. Prior,Jeanette A. Krause,Allen G. Oliver,Babu L. Tekwani,M. Omar F. Khan
Polyhedron.2019;163(4)42
[DOI]
37Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads
Joachim Kloehn,Eleanor C. Saunders,Malcolm J. McConville
Polyhedron.2016;163(4)83
[DOI]
38Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis
Aarthy C. Vallur,Yeung L. Tutterrow,Raodoh Mohamath,Sowmya Pattabhi,Asrat Hailu,Asim O. Abdoun,Abdalla E. Ahmed,Maowia Mukhtar,Md Abdus Salam,Meirielly Lima Almeida,Roque P. Almeida,Dinesh Mondal,Audrey Albertini,Hashim Ghalib,Malcolm S. Duthie,Steven G. Reed
BMC Infectious Diseases.2015;15(1)83
[DOI]
39Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
Rishikesh Kumar,Ganesh Chandra Sahoo,Krishna Pandey,V.N.R. Das,Roshan K. Topno,Md Yousuf Ansari,Sindhuprava Rana,Pradeep Das
Materials Science and Engineering: C.2016;59(1)748
[DOI]
40Slow pace of antileishmanial drug development
Awanish Kumar,Satish Chandra Pandey,Mukesh Samant
Parasitology Open.2018;4(1)748
[DOI]
41In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis
Supriya Khanra,Subir Kumar Juin,Junaid Jibran Jawed,Sweta Ghosh,Shreyasi Dutta,Shaik Abdul Nabi,Jyotirmayee Dash,Dipak Dasgupta,Subrata Majumdar,Rahul Banerjee,Abhay R. Satoskar
PLOS Neglected Tropical Diseases.2020;14(8)e0008575
[DOI]
42Concerted Efforts to Control or Eliminate Neglected Tropical Diseases: How Much Health Will Be Gained?
Sake J. de Vlas,Wilma A. Stolk,Epke A. le Rutte,Jan A. C. Hontelez,Roel Bakker,David J. Blok,Rui Cai,Tanja A. J. Houweling,Margarete C. Kulik,Edeltraud J. Lenk,Marianne Luyendijk,Suzette M. Matthijsse,William K. Redekop,Inge Wagenaar,Julie Jacobson,Nico J. D. Nagelkerke,Jan H. Richardus,Song Liang
PLOS Neglected Tropical Diseases.2016;10(2)e0004386
[DOI]
43Miltefosine Resistant Field Isolate From Indian Kala-Azar Patient Shows Similar Phenotype in Experimental Infection
Supriya Khanra,Nibedeeta R. Sarraf,Anjan K. Das,Syamal Roy,Madhumita Manna
Scientific Reports.2017;7(1)e0004386
[DOI]
44Application of Dendrimers for the Treatment of Infectious Diseases
Zandile Mhlwatika,Blessing Aderibigbe
Molecules.2018;23(9)2205
[DOI]
45Application of Dendrimers for the Treatment of Infectious Diseases
Colette L. M. van Hees,Ben Naafs
Molecules.2016;23(9)291
[DOI]
46A Mathematical Study to Control Visceral Leishmaniasis: An Application to South Sudan
Indrajit Ghosh,Tridip Sardar,Joydev Chattopadhyay
Bulletin of Mathematical Biology.2017;79(5)1100
[DOI]
47Interaction of KMP-11 and its mutants with ionic liquid choline dihydrogen phosphate: Multispectroscopic studies aided by docking and molecular dynamics simulations
Saumen Saha,Achinta Sannigrahi,Krishnananda Chattopadhyay,Joydeep Chowdhury
Journal of Molecular Liquids.2020;301(5)112475
[DOI]
48Interaction of KMP-11 and its mutants with ionic liquid choline dihydrogen phosphate: Multispectroscopic studies aided by docking and molecular dynamics simulations
Philippe M. Loiseau,Gillian Barratt
Journal of Molecular Liquids.2013;301(5)321
[DOI]
49Drug delivery: lessons to be learnt fromLeishmaniastudies
CD Shaw,KC Carter
Nanomedicine.2014;9(10)1531
[DOI]
50m -Nitrocinnamic Acid Containing Lipophilic Peptide Exhibits Selective Growth Inhibition Activity against Leishmania major
Mintu Debnath,Mazharul Abbasi,Supriya Sasmal,Rupak Datta,Debasish Haldar
ChemistrySelect.2019;4(1)116
[DOI]
51m -Nitrocinnamic Acid Containing Lipophilic Peptide Exhibits Selective Growth Inhibition Activity against Leishmania major
Joachim Müller,Andrew Hemphill
ChemistrySelect.2013;301(1)359
[DOI]
52Investigation of Calcium Channel Blockers as Antiprotozoal Agents and Their Interference in the Metabolism ofLeishmania (L.) infantum
Juliana Quero Reimão,Juliana Tonini Mesquita,Daiane Dias Ferreira,Andre Gustavo Tempone
Evidence-Based Complementary and Alternative Medicine.2016;2016(1)1
[DOI]
53Meglumine [email protected] nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect
Emrah Sefik Abamor,Adil M. Allahverdiyev,Melahat Bagirova,Miriam Rafailovich
Acta Tropica.2017;169(1)30
[DOI]
54Immunity to visceral leishmaniasis: implications for immunotherapy
Forough Khadem,Jude E Uzonna
Future Microbiology.2014;9(7)901
[DOI]
55Targeting Trypanothione Reductase of Leishmanial major to Fight Against Cutaneous Leishmaniasis
Abdul Aziz A. Bin Dukhyil
Infectious Disorders - Drug Targets.2019;19(4)388
[DOI]
56NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis
Dirlei Nico,Fernanda Martins Almeida,Juliana Maria Motta,Fellipe Soares dos Santos Cardoso,Celio Geraldo Freire-de-Lima,Leonardo Freire-de-Lima,Paula Melo de Luca,Ana Maria Blanco Martinez,Alexandre Morrot,Clarisa Beatriz Palatnik-de-Sousa
Frontiers in Immunology.2018;9(4)388
[DOI]
57In Vitro Anti-Leishmanial Effect of Metallic Meso-Substituted Porphyrin Derivatives against Leishmania braziliensis and Leishmania panamensis Promastigotes Properties
Fabian Espitia-Almeida,Carlos Díaz-Uribe,William Vallejo,Doris Gómez-Camargo,Arnold R. Romero Bohórquez
Molecules.2020;25(8)1887
[DOI]
58Immunotherapeutic potential of Leishmania ( Leishmania ) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis
Arnold R. Keerti,Narendra K. Yadav,Sumit Joshi,Sneha Ratnapriya,Amogh A. Sahasrabuddhe,Anuradha Dube
Vaccine.2018;36(17)2293
[DOI]
59Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
Shabi Parvez,Ganesh Yadagiri,Mallikarjuna Rao Gedda,Aakriti Singh,Om Prakash Singh,Anurag Verma,Shyam Sundar,Shyam Lal Mudavath
Scientific Reports.2020;10(1)2293
[DOI]
60The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression
Baibaswata Saha,Kalpana Pai,Shyam Sundar,Maitree Bhattacharyya,Neelam Prakash Bodhale
Cytokine.2020;10(1)155300
[DOI]
61Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection
S.A. Campbell,J. Alawa,B. Doro,F.L. Henriquez,C.W. Roberts,A. Nok,C.B.I. Alawa,M. Alsaadi,A.B. Mullen,K.C. Carter
Vaccine.2012;30(7)1357
[DOI]
62Cholesterol-lowering drug, in combination with chromium chloride, induces early apoptotic signals in intracellular L. donovani amastigotes, leading to death
Amit Kumar Verma,Bhakti Laha,Monika Pandey,Uttariya Pal,Monidipa Ghosh
Journal of Biosciences.2017;42(3)427
[DOI]
63Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
Elisangela Oliveira Freitas,Dirlei Nico,Marcus Vinícius Alves-Silva,Alexandre Morrot,Keith Clinch,Gary B. Evans,Peter C. Tyler,Vern L. Schramm,Clarisa B. Palatnik-de-Sousa,Michael P Pollastri
PLOS Neglected Tropical Diseases.2015;9(12)e0004297
[DOI]
64Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities
Lyn-Marie Birkholtz,Marni Williams,Jandeli Niemand,Abraham I. Louw,Lo Persson,Olle Heby
Biochemical Journal.2011;438(2)229
[DOI]
65Host resistance to visceral leishmaniasis: prevalence and prevention
Naiara Maran,Pollyanna Stephanie Gomes,Leonardo Freire-de-Lima,Elisangela Oliveira Freitas,Célio Geraldo Freire-de-Lima,Alexandre Morrot
Expert Review of Anti-infective Therapy.2016;14(4)435
[DOI]
66Fungal fatal attraction: a mechanistic review on targeting liposomal amphotericin B (AmBisome®) to the fungal membrane
Linda Soo Hoo
Journal of Liposome Research.2017;27(3)180
[DOI]
67Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno,Jeremy N. Burrows,Ken Duncan,Rob Hooft van Huijsduijnen,Takushi Kaneko,Kiyoshi Kita,Charles E. Mowbray,Dennis Schmatz,Peter Warner,B. T. Slingsby
Nature Reviews Drug Discovery.2015;14(11)751
[DOI]
68Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar
Supriya Khanra,Nibedeeta Rani Sarraf,Shantanabha Das,Anjan Kumar Das,Syamal Roy,Madhumita Manna
Acta Tropica.2016;164(11)177
[DOI]
69A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan
Suzette S. Kämink,Simon M. Collin,Tim Harrison,Francis Gatluak,Abdul Wasay Mullahzada,Koert Ritmeijer,Diana N. J. Lockwood
PLOS Neglected Tropical Diseases.2017;11(10)e0005921
[DOI]
70Development of Luciferase Expressing Leishmania donovani Axenic Amastigotes as Primary Model for In Vitro Screening of Antileishmanial Compounds
Diana N. J. Ravinder,Diana N. J. Bhaskar,Sonali Gangwar,Neena Goyal
Current Microbiology.2012;65(6)696
[DOI]
71Development of Luciferase Expressing Leishmania donovani Axenic Amastigotes as Primary Model for In Vitro Screening of Antileishmanial Compounds
Louis Maes,Raquel Andreia Inocencio da Luz,Paul Cos,Vanessa Yardley
Current Microbiology.2013;65(6)301
[DOI]
72Neolignans isolated from twigs of Nectandra leucantha Ness & Mart (Lauraceae) displayed in vitro antileishmanial activity
Simone S Grecco,Thais A Costa-Silva,Fernanda S Sousa,Stefano B Cargnelutti,Eric Umehara,Poliana S Mendonça,Andre G Tempone,Joao Henrique G Lago
Journal of Venomous Animals and Toxins including Tropical Diseases.2018;24(1)301
[DOI]
73In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin
Supriya Khanra,Y. Pavan Kumar,Jyotirmayee Dash,Rahul Banerjee
BMC Research Notes.2018;11(1)301
[DOI]
74Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India: Table 1.
Nowneet Kumar Bhat,Vivek Ahuja,Minakshi Dhar,Sohaib Ahmad,Neerul Pandita,Vibha Gupta,Smita Chandra
Journal of Tropical Pediatrics.2016;11(1)fmw056
[DOI]
75Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity
Patrícia Valéria Castelo-Branco,Hugo José Alves,Raissa Lacerda Pontes,Vera Lucia Maciel-Silva,Silma Regina Ferreira Pereira
International Journal for Parasitology: Drugs and Drug Resistance.2019;9(1)8
[DOI]
76Análisis de la utilización de anfotericina B liposomal
María González Martínez,Carolina Mariño Martínez,Gema Baldominos Utrilla,María Nélida Fernández Martínez
Revista Iberoamericana de Micología.2014;31(2)109
[DOI]
77Development of Vaccines against Visceral Leishmaniasis
Krystal J. Evans,Lukasz Kedzierski
Journal of Tropical Medicine.2012;2012(2)1
[DOI]
78Lipid synthesis in protozoan parasites: A comparison between kinetoplastids and apicomplexans
Srinivasan Ramakrishnan,Mauro Serricchio,Boris Striepen,Peter Bütikofer
Progress in Lipid Research.2013;52(4)488
[DOI]
79Lipid synthesis in protozoan parasites: A comparison between kinetoplastids and apicomplexans
M. Freissmuth
Progress in Lipid Research.2016;52(4)771
[DOI]
80Epidemiologic Correlates of Mortality among Symptomatic Visceral Leishmaniasis Cases: Findings from Situation Assessment in High Endemic Foci in India
Aritra Das,Morchan Karthick,Shweta Dwivedi,Indranath Banerjee,Tanmay Mahapatra,Sridhar Srikantiah,Indrajit Chaudhuri,Claudia Munoz-Zanzi
PLOS Neglected Tropical Diseases.2016;10(11)e0005150
[DOI]
81Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery
David Mendes Costa,Pedro Cecílio,Nuno Santarém,Anabela Cordeiro-da-Silva,Joana Tavares
Scientific Reports.2019;9(1)e0005150
[DOI]
82Autophagy in Trypanosomatids
Ana Brennand,Eva Rico,Paul A. M. Michels
Cells.2012;1(3)346
[DOI]
83LEISHMANICIDAL ACTIVITY in vivo OF A MILTEFOSINE DERIVATIVE IN Mesocricetus auratus
Joana C. da Silva,Juliana B. Nunes,Vanessa S. Gontijo,Luiz Cosme C. Malaquias,Rossimiriam P. de Freitas,Rosemeire B. Alves,Fabio A. Colombo,Marcia D. Laurenti,Marcos J. Marques
Acta Tropica.2020;209(3)105539
[DOI]
84Adjunct Therapy of rIFN-g and rIL-17A along with Sub-optimal Dose of Amphotericin-B effectively Control the Leishmania donovani Parasitic Growth in Infected Mice
Prabin Kumar,Pragya Misra,Abhinav Saurabh,Narayan Rishi,Dipendra Kumar Mitra
Journal of Pure and Applied Microbiology.2018;12(4)1771
[DOI]
85Adjunct Therapy of rIFN-g and rIL-17A along with Sub-optimal Dose of Amphotericin-B effectively Control the Leishmania donovani Parasitic Growth in Infected Mice
Scott Worswick,Sean Dreyer
Journal of Pure and Applied Microbiology.2018;12(4)471
[DOI]
86Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
Michael G. Thomas,Manu De Rycker,Myriam Ajakane,Sébastian Albrecht,Ana Isabel Álvarez-Pedraglio,Markus Boesche,Stephen Brand,Lorna Campbell,Juan Cantizani-Perez,Laura A.T. Cleghorn,Royston C.B. Copley,Sabrinia D. Crouch,Alain Daugan,Gerard Drewes,Santiago Ferrer,Sonja Ghidelli-Disse,Silvia Gonzalez,Stephanie L. Gresham,Alan P. Hill,Sean J. Hindley,Rhiannon M. Lowe,Claire J. MacKenzie,Lorna MacLean,Sujatha Manthri,Franck Martin,Juan Miguel-Siles,Van Loc Nguyen,Suzanne Norval,Maria Osuna-Cabello,Andrew Woodland,Stephen Patterson,Imanol Pena,Maria Teresa Quesada-Campos,Iain H. Reid,Charlotte Revill,Jennifer Riley,Jose Ramon Ruiz-Gomez,Yoko Shishikura,Frederick R.C. Simeons,Alasdair Smith,Victoria C. Smith,Daniel Spinks,Laste Stojanovski,John Thomas,Stephen Thompson,Tim Underwood,David W. Gray,Jose M. Fiandor,Ian H. Gilbert,Paul G. Wyatt,Kevin D. Read,Timothy J. Miles
Journal of Medicinal Chemistry.2019;62(3)1180
[DOI]
87Enkephalins as a therapeutic intervention for visceral leishmaniasis
Ganesh Yadagiri,Shyam Lal Mudavath
Medical Hypotheses.2020;144(3)109956
[DOI]
88Is leishmaniasis an “unusual suspect” of infection in allogeneic transplantation?
A. Komitopoulou,T. Tzenou,J. Baltadakis,J. Apostolidis,D. Karakasis,N. Harhalakis
Transplant Infectious Disease.2014;16(6)1012
[DOI]
89Is leishmaniasis an “unusual suspect” of infection in allogeneic transplantation?
Sarah Hendrickx,Louis Maes,Simon L. Croft,Guy Caljon
Transplant Infectious Disease.2018;16(6)193
[DOI]
90Investigation of the Anti-Leishmania (Leishmania) infantum Activity of Some Natural Sesquiterpene Lactones
Imke Wulsten,Thais Costa-Silva,Juliana Mesquita,Marta Lima,Mariana Galuppo,Noemi Taniwaki,Samanta Borborema,Fernando Da Costa,Thomas Schmidt,Andre Tempone
Molecules.2017;22(5)685
[DOI]
91An unusual case of anaemia in an octogenarian
L. McCusker,J. Platt
Age and Ageing.2012;41(5)696
[DOI]
92Evaluating the immunomodulatory responses of Ld ODC-derived MHC Class-II restricted peptides against VL
RajKishor Pandey,Manas Ranjan Dikhit,Avinash Kumar,Budheswar Dehury,Krishna Pandey,Roshan Kamal Topno,Pradeep Das,Sanjiva Bimal
Parasite Immunology.2020;42(4)696
[DOI]
93Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation
Yetemwork Aleka,Ana Victoria Ibarra-Meneses,Meseret Workineh,Fitsumbrhan Tajebe,Amare Kiflie,Mekibib Kassa Tessema,Roma Melkamu,Azeb Tadesse,Javier Moreno,Johan van Griensven,Eugenia Carrillo,Wim Adriaensen
Journal of Immunology Research.2020;2020(4)1
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008